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2001.—Activation of pituitary angiotensin (ANG II) type 1
receptors (AT1) mobilizes intracellular Ca
21, resulting in
increased prolactin secretion. We first assessed desensitiza-
tion of AT1 receptors by testing ANG II-induced intracellular
Ca21 concentration ([Ca21]i) response in rat anterior pitu-
itary cells. A period as short as 1 min with 1027 M ANG II
was effective in producing desensitization (remaining re-
sponse was 66.8 6 2.1% of nondesensitized cells). Desensiti-
zation was a concentration-related event (EC50: 1.1 nM).
Although partial recovery was obtained 15 min after removal
of ANG II, full response could not be achieved even after 4 h
(77.6 6 2.4%). Experiments with 5 3 1027 M ionomycin
indicated that intracellular Ca21 stores of desensitized cells
had already recovered when desensitization was still signif-
icant. The thyrotropin-releasing hormone (TRH)-induced in-
tracellular Ca21 peak was attenuated in the ANG II-pre-
treated group. ANG II pretreatment also desensitized ANG
II- and TRH-induced inositol phosphate generation (72.8 6
3.5 and 69.6 6 6.1%, respectively, for inositol triphosphate)
and prolactin secretion (53.4 6 2.3 and 65.1 6 7.2%), effects
independent of PKC activation. We conclude that, in pitu-
itary cells, inositol triphosphate formation, [Ca21]i mobiliza-
tion, and prolactin release in response to ANG II undergo
rapid, long-lasting, homologous and heterologous desensiti-
zation.
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ANGIOTENSIN II (ANG II) type 1 (AT1) receptors belong to
the family of plasma membrane receptors that couple
to guanine nucleotide regulatory proteins [guanine nu-
cleotide protein-coupled receptors (GPCR)]. Two sub-
types have been described: AT1A and AT1B. In the rat
pituitary, activation of AT1B receptors coupled to Gq/11
protein increases phospholipase C-b (PLC-b) activity,
resulting in increased inositol 1,4,5-triphosphate
[Ins(1,4,5)P3] and diacylglycerol formation. A biphasic
increase in intracellular calcium concentration ([Ca21]i)
triggered by Ins(1,4,5)P3 ensues. In a previous study
(16) we showed that the initial transient [Ca21]i spike,
which is primarily due to Ins(1,4,5)P3-mediated release
of intracellular Ca21, is followed by a sustained [Ca21]i
elevation that results from increased Ca21 influx through
voltage-sensitive calcium channels and capacitative
Ca21 entry. The initial [Ca21]i spike is terminated as
Ins(1,4,5)P3 concentration declines, intracellular Ca
21
stores become exhausted, and cytoplasmic Ca21 is se-
questered by intracellular organelles or pumped out
from the cells. DAG, together with the increased [Ca21]i,
stimulates protein kinase C (PKC) activity. Activation
of this pathway by ANG II in lactotrophs results in
prolactin secretion (10).
It is well recognized that, in the presence of agonists,
many transmembrane GPCRs not only display rapid
activation of signal transduction but also rapid desen-
sitization of response (31). Receptor desensitization is
potentially a physiologically important process, as it
provides a means of regulating continuous receptor
stimulation. Rapid receptor desensitization does not
necessarily involve receptor loss but rather receptor
phosphorylation (36). This acute process (seconds to
minutes) may be supplemented by internalization
(minutes to hours) and by downregulation (hours to
days) of membrane receptors.
Both AT1 receptor subtypes (AT1A and AT1B) un-
dergo rapid homologous desensitization in response to
ANG II. This has been reported in the adrenal gland
(28), vascular smooth muscle cells (2), rat cardiomyo-
cytes (1), renal afferent arterioles (21), brain (14), and
Chinese hamster ovary (CHO) cells (34). In particular,
desensitization of ANG II receptors in the pituitary has
not been documented. Different degrees and temporal
patterns of desensitization have been reported for
PLC-b-coupled receptors, and it is believed that desen-
sitization may be a cell-specific phenomenon, regulated
by differential expression of elements involved in the
process. Moreover, it is well established that signaling
and desensitization of GPCRs can be influenced by the
cell type in which they are expressed, as in the case of
the mouse thyrotropin-releasing hormone (TRH) recep-
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tor (12). This raises the possibility that ANG II desen-
sitization may be a function of the cell type rather than
of AT1 receptor structure.
We therefore assessed whether rapid desensitization
of the AT1 receptor occurs in anterior pituitary cells by
use of repetitive stimulation of intracellular Ca21 mo-
bilization, inositol triphosphate generation, and pro-
lactin secretion as end points. We also determined
whether heterologous desensitization occurred by use
of TRH as a second alternative stimulus and the par-
ticipation of PKC in the desensitization process.
MATERIALS AND METHODS
Animals. Female 60-day-old Sprague-Dawley rats were
housed in an air-conditioned room with lights on at 0700 and
off at 1900. They had free access to laboratory chow and tap
water. Female rats were checked by vaginal cytology for
regular estrous cycles during $10 days previous to the ex-
periment. Rats in diestrus were used.
Cell dispersion. Unless specified, all drugs were purchased
from Sigma (St. Louis, MO).
Rats were killed by decapitation at 9:00 AM, and pituitar-
ies were removed on ice, separated from the neurointerme-
diate lobe, and placed in chambers containing freshly pre-
pared Krebs-Ringer bicarbonate buffer (KRBGA) without
Ca21 or Mg21. Buffer contained 14 mM glucose, 1% bovine
seroalbumin, MEM amino acids 2%, MEM vitamins 1%
(GIBCO, Buenos Aires, Argentina), 2 mM glutamine, and
Phenol Red 0.025%. It was previously gassed for 15 min with
95% O2-5% CO2 and adjusted to pH 7.35–7.40. Buffer was
sterilized by filtration through a 0.45-mm pore diameter
membrane (Nalgene). Pituitaries were washed three times
with KRBGA and then cut into 1-mm pieces. Fragments
obtained were washed and incubated in the same buffer
containing 0.5% trypsin for 30 min at 37°C, with 95% O2-5%
CO2. They were treated for two additional minutes with 50 ml
DNase I (1 mg/ml, Worthington, Lakewood, NJ). Digestion
was ended by addition of 1 mg/ml LBI. Fragments were
dispersed in individual cells by gentle trituration through
siliconized Pasteur pipettes. Resulting suspension was fil-
tered through a nylon gauze (160 mm) and centrifuged for 10
min at 120 g. Before centrifugation, an aliquot of cellular
suspension was taken to quantify hypophysial cell yield by
use of a Neubauer chamber. Viability of cells, determined by
trypan blue exclusion, was always .90%. In a series of
experiments, cells were freshly used for intracellular Ca21
measurements; alternatively, they were cultured for 4 days
(as will be described).
Intracellular Ca21 measurements. Measurements were
made as previously described (11). Briefly, the tetraace-
toxymethyl ester (AM) of fura 2 was used as a fluorescent
indicator. The pellet of anterior pituitary cells of each exper-
imental group was redispersed and incubated in a buffered
saline solution (BSS: 140 mM NaCl, 3.9 mM KCl, 0.7 mM
KH2PO4, 0.5 mM Na2HPO4 z12H2O, 1 mM CaCl2, 0.5 mM
MgCl2, and 20 mM HEPES, pH 7.4) in the presence of 1.5 mM
fura 2-AM, 10 mM glucose, and 0.1% BSA. Cells were incu-
bated for 30 min at 37°C in an atmosphere of 95% O2-5%
CO2, a time during which fura 2 is trapped intracellularly by
esterase cleavage. Cells were then washed twice in BSS
without fura 2-AM and brought to a density of 1.7–2 3 106
cells/ml BSS. Fluorescence was measured in a spectroflu-
orometer (Jasco, Tokyo, Japan) provided with the accessory
CA-261 to measure Ca21 with continuous stirring, a thermo-
stat adjusted to 37°C, and an injection chamber. Intracellular
Ca21 levels were registered every second by exposure to
alternating 340- and 380-nm light beams, and the intensity
of light emission at 505 nm was measured. In this way light
intensities and their ratio (F340/F380) were followed. Drugs
were injected (5 ml) into the chamber as a 100-fold concen-
trated solution without interruption of recording. The prep-
aration was calibrated, and maximal fluorescence (Fmax) was
determined by addition of 0.1% Triton X-100 and minimal
fluorescence (Fmin) in the presence of 6 mM EGTA (pH
adjusted to .8.3). [Ca21]i was calculated according to Gryn-
kiewicz (17). Unless specified, basal values were considered
those measured during 20 s before the addition of ANG II.
Values were corrected for dye leakage, as described in Refs.
15 and 17, and for autofluorescence with unlabeled cells.
Both dye leakage and autofluorescence were minimal.
To assess the concentration of ANG II at which homolo-
gous desensitization occurs, experiments were conducted by
applying an initial stimulus of ANG II in concentrations
ranging from 1 3 10210 to 1 3 1027 M at minute 1 and a
second stimulus of 1 3 1027 M ANG II 2 min later. [Ca21]i
was monitored as described.
To determine the briefest period of ANG II exposure that
would cause desensitization, 1027 M ANG II or buffer was
applied for varying periods (1, 5, 10, and 20 min) to cells in
culture (see Cell culture). Stimulus was removed by extensive
washing, and cells were resuspended with 0.01% trypsin and
0.02% BSS-EDTA and tested for 1 3 1027 M ANG II-induced
Ca21 mobilization 2 h after first stimulus.
To determine the period needed to recover from desensiti-
zation of Ca21 mobilization induced by ANG II, the following
experiment was performed. Desensitization of the ANG II
response was induced by exposing dispersed cells to 1 3 1027
M ANG II for 10 min. Cells were then washed repeatedly to
remove ANG II and maintained in ANG II-free medium for
15, 30, 60, 120, 180, or 240 min before the reintroduction of
1027 M ANG II and testing of the Ca21 response. Buffer-
exposed cells were tested in parallel.
Effect of ionomycin and TRH on [Ca21]i in ANG II-desen-
sitized cells. Desensitization of the ANG II response was
elicited by exposing dispersed cells to 1 3 1027 M ANG II for
10 min. Cells were then washed repeatedly to remove ANG II
and maintained in ANG II-free medium for 2 h before appli-
cation of 5 3 1027 M ionomycin or 1 3 1027 M TRH and
testing of the Ca21i response. Control cells were pretreated
with buffer and similarly treated thereafter.
Cell culture. Cell pellets were resuspended in DMEM,
supplemented with 10% horse serum, 2.5% fetal calf serum,
1% MEM nonessential amino acids, 25,000 U/l of nystatin,
and 25 ng/l gentamicin. Cells were plated in sterile tissue
culture plates (Cluster 24, Corning; 500,000 cells per well)
and incubated with 1 ml DMEM (GIBCO) in a metabolic
incubator at 37°C with 5% CO2-95% O2.
Desensitization of ANG II-induced cellular inositol phos-
phate accumulation and prolactin secretion. After 4 days in
culture, cells were washed twice with DMEM and F-12 Nu-
trient Mixture (GIBCO), supplemented with 1% BSA, 2 mM
glutamine, and the same concentration of antibiotics, to
remove all traces of serum. Fresh medium containing 4
mCi/ml myo-[2-3H(N)]inositol (specific activity: 20 Ci/mmol;
New England Nuclear, Boston, MA) was added, and cells
were incubated at 37°C for 24 h. At the end of the labeling
period, cells were washed twice with DMEM-F-12 supple-
mented with 1% BSA, 2 mM glutamine, 25,000 U/l nystatin,
and 25 ng/l gentamicin. Cells were pretreated with buffer or
first stimulated with 1 3 1027 ANG II for 10 min, and
stimulus was removed by washing. Thereafter, cells were
further incubated for 105 min in DMEM-F12. Medium was
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replaced, and cells were incubated with 20 mM LiCl for 15
min to allow accumulation of inositol phosphate species. A
second stimulus of 1 3 10 29 or 1 3 10 27 M ANG II, 1 3 10
27 M TRH, or buffer (control) was then applied to the cells in
duplicate. For analysis of prolactin secretion, samples were
taken 30 min after drug administration. Samples were stored
at 220°C until analyzed by RIA after appropriate dilution in
0.01 M PBS with 1% egg albumin. Cells were placed on ice,
treated with 0.5 M cold perchloric acid, and scraped for
inositol phosphate determination. Experiments were re-
peated four times. Times and concentrations were chosen
according to our previous experience (4).
Inositol phosphate accumulation. Inositol phosphates were
measured as previously described (3), with minor modifica-
tions. Well contents were transferred to tubes and centri-
fuged for 10 min at 3,000 rpm (4°C). Pellets were kept for
DNA measurement. The supernatants were neutralized (0.72
M KOH-0.6 M HKCO3) and chromatographed on Dowex
columns (AG-1-X8, 200–400 mesh, formate form, Bio-Rad,
Buenos Aires, Argentina) to elute inositol monophosphate
(InsP), diphosphate (InsP2), and triphosphate (InsP3). Phos-
phate esters were eluted by the stepwise addition of solutions
containing increasing levels of formate. Specifically, they
were sequentially eluted with 10 mM inositol (for free [3H]-
inositol), 0.1 M formic acid and 0.2 M ammonium formate (for
InsP), 0.1 M formic acid and 0.4 M ammonium formate (for
InsP2), and 0.1 M formic acid and 1.0 M ammonium formate
(for InsP3). Two-milliliter aliquots of each wash fraction were
mixed with 6 ml Optiphase “Hisafe” 3 (Wallac Oy, Turku,
Finland) and counted in a liquid scintillation counter.
PKC downregulation. PKC was downregulated in vitro by
a 24-h pretreatment of cultured cells with 1 mM phorbol
12-myristate 13-acetate (PMA). Homologous and heterolo-
gous desensitization of prolactin response by ANG II pre-
treatment was tested as we have described. Downregulation
of PKC was confirmed by the inability of a 30-min stimula-
tion with 1 mM PMA (PMA30) to release prolactin in PMA-
pretreated cells (PMA24), (PMA30: 274.5 6 52.0;
PMA301PMA24: 9.4 6 12.6 prolactin increase in ng/ml, P 5
0.023).
RIA. Prolactin was measured by RIA using kits provided
by the National Institute of Diabetes and Digestive and
Kidney Diseases. Results are expressed in terms of prolactin
PRL RP3. Intra- and interassay coefficients of variation were
7.2 and 12.8%, respectively.
Statistical analyses. Results are expressed as means 6 SE.
For [Ca21]i measurements, peak values were analyzed by
one-way ANOVA for repeated measures. Individual means
were then compared by Duncan’s test (desensitized vs. con-
trol). Prolactin secretion and inositol phosphate generation
in vitro were analyzed by two-way ANOVA for repeated
measures for the effects of drug treatment and group (control
or desensitized). If an F of interaction was found significant,
individual means were compared by Scheffé’s test; if it was
not significant, groups of means were analyzed by the same
test. Basal prolactin and inositol phosphates were analyzed
by Student’s t-test. P , 0.05 was considered significant.
RESULTS
Desensitization of ANG II-mediated increase in
[Ca21]i . The amplitude of the [Ca
21]i spike depended
on ANG II concentration, reaching an apparent maxi-
mum at 10 nM. At higher concentrations, the [Ca21]i
response occurred earlier and more synchronically,
with a steeper upstroke (Fig. 1). The EC50 for peak
amplitude was 2.3 nM.
To determine the ANG II concentration needed to
elicit maximal desensitization, we tested the effect of
pretreatment with increasing concentrations of ANG II
on the ability of 1 3 1027 M ANG II to stimulate Ca21
mobilization 120 s later. Desensitization was observed
in response to an ANG II concentration as low as 1 3
10210 M (90.1 6 4.4% of control), and it was significant
at 1 3 1029 M ANG II (34.2 6 3.9% of control, P 5
0.011; Fig. 2). Incubation of cells with 1 3 1027 M ANG
II completely abolished the [Ca21]i response to a sec-
ond exposure to 1 3 1027 M ANG II. A desensitizing
concentration of 1 3 1027 M was therefore used in
subsequent experiments. A first-order (linear) regres-
sion model was applied to the transformed data [logit
(%response) vs. log (ANG II)], yielding a square of the
correlation coefficient (r2) of 0.97 and a predicted value
of 50% desensitization of 1.1 nM ANG II.
Incubation time required for desensitization. To de-
termine the briefest ANG II exposure that would cause
desensitization, 1 3 1027 M ANG II was applied for
varying periods of time (1, 5, 10, or 20 min) to pituitary
cells in culture. Cells were washed repeatedly and
subjected to a second 1 3 1027 M ANG II pulse after
120 min. ANG II-induced [Ca21]i increase was already
desensitized after 1 min of pretreatment (Fig. 3). The
response obtained was 66.8 6 2.1% of maximal re-
sponse (P 5 0.044), and this percentage did not change
significantly with increasing incubation periods. For
subsequent experiments, a 10-min pretreatment was
chosen.
Recovery of Ca21 response. In light of the suscepti-
bility of cells to desensitization, we further assessed
the ability of desensitized cells to recover. Cells were
subjected to a 10-min pretreatment with 1 3 1027 M
ANG II and then washed with medium devoid of
Fig. 1. Effect of various angiotensin (ANG) II concentrations (1 3
10210 to 1 3 1027 M) on %increase of intracellular calcium concen-
tration ([Ca21]i) over basal levels in dispersed anterior pituitary
cells. Basal levels were considered as the average of [Ca21]i 20 s
before the ANG II stimulus, which was applied at minute 1; basal
[Ca21]i averaged 174 6 35 nM. Lines represent the average for each
time point, with thin lines on top or below, 1 SE; n 5 6 for each
concentration. (In all figures, n indicates nos. of experiments on
different days, each performed in replicate from a batch of cells
derived from $3 rats.)
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ANG II and incubated for varying periods before the
second pulse of 1 3 1027 M ANG II. The Ca21 re-
sponse recovered partially after 15 min but remained
at only 41.4 6 2.6% of the control response (P 5
0.00016 vs. control). The response to ANG II was
still different from the control value 4 h after the
initial ANG II stimulus (77.6 6 2.4%, P 5 0.00022;
Fig. 4).
Recovery of intracellular Ca21 stores after a desensi-
tizing stimulus of ANG II. To test the possible involve-
ment of intracellular Ca21 pool depletion, we compared
the effects of the Ca21 ionophore ionomycin (5 3 1027
M) on [Ca21]i mobilization in control cells and in cells
desensitized with a 10-min pretreatment of 1 3 1027 M
ANG II 2 h earlier. We found that the increase in
[Ca21]i in response to ionomycin was not different in
control and desensitized cells (Fig. 5), suggesting that
intracellular Ca21 stores had already recovered by the
time desensitization was still significant.
Heterologous desensitization of intracellular Ca21
mobilization. To investigate whether a pretreatment
with 1 3 1027 M ANG II produced heterologous desen-
sitization, 1 3 1027 M TRH was applied 2 h after a
10-min pretreatment with buffer or 1 3 1027 M ANG
II, and [Ca21]i was monitored. As observed in Fig. 6,
the TRH-induced Ca21 peak was attenuated in the
ANG II-pretreated group and reached only 60.3% of
levels attained in the control group (P 5 0.001).
Fig. 2. Pretreatment with increasing concentrations of
ANG II (A; minute 1, 1st arrow) on the ability of 1 3
1027 M ANG II to stimulate intracellular Ca21 mobili-
zation 2 min later (second arrow). Results are ex-
pressed as %increase of [Ca21]i over basal levels. Keys
express 1st and 2nd concentrations of ANG II used.
Bottom right: %[Ca21]i spike response remaining after
a desensitizing (Dsn) stimulus of ANG II for each con-
centration. Spike increase in buffer-pretreated cells
(Buff; upper left) was considered as 100%. *P , 0.011
vs. control (buffer pretreatment); n 5 6 experiments.
The desensitizing effect of ANG II was concentration
dependent with an EC50 of 1.1 nM.
Fig. 3. Effect of duration of 1 3 1027 M ANG II pretreatment (1, 5,
10, or 20 min) on intracellular Ca21 response to a second 1 3 1027 M
ANG II stimulus applied 2 h later. Percent desensitized (Dsn) re-
sponse remaining was calculated as spike [Ca21]i increase in ANG
II-pretreated cells in relation to spike increase in buffer-pretreated
cells, which was considered as 100%. Values are means 6 SE of 4
experiments. *P , 0.05 vs. buffer pretreatment (open bar); n 5 5
experiments.
E465DESENSITIZATION OF ANG II RECEPTOR IN PITUITARY CELLS
ANG II-mediated homologous and heterologous de-
sensitization of inositol phosphate generation. To ascer-
tain whether homologous and heterologous desensiti-
zation of PLC-b function occurred, we determined the
effect of a 10-min pretreatment with 1 3 1027 M ANG
II on the ability of ANG II or TRH to generate inositol
phosphates 2 h later. Basal levels of the three inositol
phosphate species were increased in cells previously
treated with ANG II. Basal levels in buffer-pretreated
cells were 452.3 6 37.3, 95.4 6 8.7, and 32.63 6 2.79
counts zmin21 (cpm) zmg DNA21 6 SE for InsP, InsP2,
and InsP3, respectively, and in ANG II-pretreated
cells, levels were 802.2 6 57.3, 171.6 6 12.8, and
52.65 6 1.67 cpm/mg DNA (P 5 0.038 control vs. de-
sensitized for the three inositol phosphate species).
Such increment was probably related to the effect of
ANG II pretreatment, which was prolonged by addition
of LiCl, which prevents inositol phosphate breakdown.
When we evaluated absolute increments after the sec-
ond stimulus, similar patterns of response were found
for the three inositol phosphate species. InsP3 produc-
tion was lower in desensitized cells (response to 1 3
1029 and 1 3 1027 M ANG II was 69.8 6 3.5 and 72.8 6
3.5% of control cells, P 5 0.045; Fig. 7, left), and both
InsP2 and InsP production was also lower in these cells
(P 5 0.05 and 0.046, respectively; Fig. 7, middle and
right). Interestingly, the response of inositol phos-
phates to 1 3 1027 M TRH was also desensitized by
previous treatment with ANG II (response was 69.6 6
6.1% that of control response for InsP3, P 5 0.045).
ANG II-mediated homologous and heterologous de-
sensitization of prolactin secretion. Response to the
secretory activity of ANG II was also desensitized,
because a pretreatment with 1 3 1027 M ANG II for 10
min significantly reduced ANG II-induced prolactin
secretion 2 h later (Fig. 8). The response was only
64.3 6 9.9 and 53.4 6 2.3% of that achieved in the
control group for the concentrations of 1 3 1029 and
1 3 1027 M ANG II, respectively (P 5 0.022). Response
of prolactin secretion to 1 3 1027 M TRH was also
decreased (65.1 6 7.2% of control response, P 5 0.022)
by a desensitizing pretreatment with ANG II.
Fig. 4. Recovery from desensitization: cells were pretreated for 10
min with buffer (control) or 1 3 1027 M ANG II and then washed
extensively and maintained without ANG II for the indicated period
(see keys) before a second stimulus of 1 3 1027 M ANG II. Traces
were arbitrarily off-set in time for clarity. Values are means 6 SE of
5 separate experiments.
Fig. 5. Effect of ionomycin on intracellular Ca21 mobilization in
control and desensitized cells. Cells were pretreated for 10 min with
buffer (control) or 1 3 1027 M ANG II (Desensitized) and then
washed extensively and maintained without ANG II for 2 h before
being stimulated with 5 3 1027 M ionomycin (arrow). Results are
expressed as %increase of [Ca21]i over basal levels (basal levels being
the average of [Ca21]i 20 s before ionomycin stimulus); n 5 4
experiments.
Fig. 6. Effect of thyrotropin-releasing hormone (TRH) on [Ca21]i
mobilization in control and desensitized cells. Cells were pretreated
for 10 min with buffer (control) or 1 3 1027 M ANG II (Desensitized)
and then washed extensively and maintained without ANG II for 2 h
before being stimulated with 1 3 1027 M TRH (arrow). Results are
expressed as %increase of [Ca21]i over basal levels (the average of
[Ca21]i 20 s before TRH stimulus); n 5 4 experiments.
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Involvement of PKC on ANG II-mediated heterolo-
gous desensitization of prolactin secretion and Ca21
mobilization. To assess the role of PKC in the agonist-
induced desensitization of the ANG II receptor, we
investigated the effect of PMA pretreatment on the
ANG II-mediated desensitization of the prolactin and
intracellular Ca21 response. PMA pretreatment (1 mM,
for 24 h) did not modify basal prolactin levels [control:
901.8 6 73.4, PMA: 807.6 6 63.0 ng/ml, not significant
(NS)]. Prolactin increment in response to ANG II and
TRH was not significantly different in buffer or PMA-
pretreated cells. As expected, prolactin response to
ANG II and TRH was lower in ANG II-desensitized
cells (Fig. 9; P 5 0.043). In PMA-pretreated cells, ANG
II-induced homologous and heterologous desensitiza-
tion was still observed.
We also tested ANG II-induced heterologous desen-
sitization of the Ca21 response to TRH in PMA-pre-
treated and untreated cells. We found that the degree
of desensitization was similar in both groups (remain-
ing response to TRH in untreated and PMA-pretreated
cells was 70.0 6 8.0 and 78.1 6 5.2%, respectively, NS).
DISCUSSION
The octapeptide ANG II binds and activates recep-
tors in the plasma membrane of target cells, thereby
Fig. 7. Desensitization of inositol phosphate (inositol monophosphate, InsP; inositol biphosphate, InsP2; inositol
triphosphate, InsP3) production elicited by ANG II in cultured pituitary cells. Cells were pretreated with buffer
(control) or with 1 3 1027 M ANG II (Desensitized) for 10 min, washed, and incubated for 2 h in agonist-free
medium. They were next stimulated with 1 3 1029 M ANG II, 1 3 1027 M ANG II, or 1 3 10 27 M TRH, and inositol
phosphates were measured 30 min thereafter. Results are expressed as absolute increment in counts zmin21
(cpm) zmg DNA21 over basal levels; they are means 6 SE of 4 independent experiments performed in duplicate.
*P , 0.05 vs. respective control cells.
Fig. 8. Desensitization of prolactin (prl; PRL) secretion induced by
ANG II in cultured pituitary cells. Cells were pretreated with buffer
(control) or with 1 3 1027 M ANG II (Desensitized) for 10 min,
washed, and incubated for 2 h in agonist-free medium. A second
stimulus of ANG II or TRH was then added, and samples were taken
30 min later. Results are expressed as absolute increment over basal
levels; they represent means 6 SE of 4 independent experiments
performed in duplicate. Basal levels of PRL release in control and
desensitized cells were 874 6 55 and 990 6 59 ng/ml (P 5 0.038).
*P 5 0.022 vs. respective undesensitized cells.
Fig. 9. Effect of 12-myristate 13-acetate (PMA) pretreatment (1 mM,
24 h) on ANG II-induced homologous and heterologous desensitiza-
tion of PRL secretion in cultured pituitary cells. Cells were treated
with buffer (control) or with 1 3 1027 M ANG II (Desensitized) for 10
min, washed, and incubated for 2 h in agonist-free medium. A second
stimulus of 1 3 1027 M ANG II (A7) or 1 3 1027 M TRH (T7) was
then added, and samples were taken 30 min later. Results are
expressed as %increment (means 6 SE) over basal levels of PRL
secretion (basal levels for control: 901.8 6 73.4 and for PMA: 807.5 6
63.0 ng/ml, not significant). *P 5 0.043 vs. respective undesensitized
cells; n 5 4 experiments.
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mediating a variety of important cardiovascular, ho-
meostatic, and neuroendocrine functions. A brain-re-
nin-ANG II, as well as a pituitary-renin-ANG II, sys-
tem has been well characterized, and there are
particularly high levels of ANG II in the hypothala-
mus. ANG II receptors are present in both the hypo-
thalamus and the anterior pituitary of several species.
Studies from numerous laboratories have shown that
ANG II affects pituitary prolactin, growth hormone,
adrenocorticotropin, and luteinizing hormone acting at
the hypothalamus and/or the pituitary, and receptor
number varies in physiologically diverse conditions
(29). We have demonstrated that ANG II activates AT1
pituitary receptors, and that inositol phosphate gener-
ation, [Ca21]i increase, and prolactin stimulation en-
sue (10, 16).
In many cells or tissues, exposure of ANG II recep-
tors to ANG II often leads to a rapid loss of receptor
responsiveness, or receptor desensitization. This has
been described in cells from the kidney, heart, adrenal
gland, and brain (1, 2, 14, 21, 28, 34). In the present
study, we describe for the first time ANG II-induced
homologous and heterologous desensitization of intra-
cellular Ca21 mobilization, InsP3 generation, and pro-
lactin release in dispersed anterior pituitary cells.
It has been documented that desensitization is an
event associated with receptor structure as well as
with the cell type in which the receptor is expressed
(12). It is therefore understandable that different tem-
poral and functional aspects of ANG II receptor desen-
sitization have been described.
The desensitization of the ANG II-induced Ca21 re-
sponse was a concentration-related phenomenon reach-
ing an apparent maximum at 1 3 1027 M, and desen-
sitization could not be overcome by using higher
concentrations of ANG II (data not shown). The EC50
that induced homologous desensitization (1.1 nM) was
in the range of the dissociation constant Kd for the AT1
receptor in the pituitary (8). It was also similar to that
obtained for ANG II-induced desensitization of Ins(1,4,5)P3
production in CHO cells (33).
In contrast to the present results, in CHO-K1 cells
expressing the AT1 receptor (34, 35) after an initial
stimulus with a subsaturating concentration (1 3 1029
M) of ANG II, no response in [Ca21]i was observed to a
second ANG II challenge added 2 min later. We ob-
served that 1 3 1029 M ANG II reduced the subsequent
response to 34.2%, which was still a significant re-
sponse. In human embryonal kidney, 293 cells stably
expressing AT1A receptors, cells initially stimulated
with 1 3 1027 M ANG II were refractory to a second
ANG II stimulus 4 min later, as in the present work
(18). Transfected cell systems represent a useful tool to
study cellular mechanisms, but they may not reliably
reflect the actual mechanism present in cells endog-
enously expressing AT1 receptors. Particularly when
desensitization is considered, discrepant results may
be related to different amounts of expressed receptors
or differential cell expression of elements involved in
the mechanism of desensitization.
We next evaluated the extent of desensitization in
relation to the duration of the initial stimulus. When
cells were stimulated by ANG II and then washed and
tested for desensitization 2 h later, an initial stimulus
as short as 1 min was effective in producing maximal
desensitization. This time course resembles desensiti-
zation of the AT1A receptor in rat cardiomyocytes and
in CHO cells, where rapid desensitization can occur
even if receptor internalization is inhibited (1, 32). This
suggests that receptor desensitization and internaliza-
tion are distinct events, even though they can occur
concurrently. In CHO cells expressing the AT1B recep-
tor, there was also a rapid (few minutes) and dose-
dependent homologous desensitization of receptor-me-
diated production of second messengers (25, 33).
Nevertheless, it has been shown that in bovine adrenal
glomerulosa cells, AT1 receptors are resistant to short-
term desensitization and that long-term pretreatments
with high concentrations of ANG II are needed to
desensitize AT1-mediated cellular responses (28). This
may reflect the influence of cell type on the AT1 recep-
tor sensitivity to desensitization.
When ANG II was washed, the cells recovered the
ability to increase [Ca21]i in response to a second ANG
II stimulus already at 15 min, even though maximal
response could not be obtained at that time. Full re-
covery from the desensitized state required more than
4 h. In CHO-K1 cells, a small response could be ob-
tained 30 min after the initial stimulus, and an incom-
plete resensitization was observed 60 min after wash-
ing the initial stimulus. In contrast, in bovine adrenal
glomerulosa cells, desensitization of the AT1B receptor
was a reversible phenomenon, because most of the
binding capacity was recovered after 60 min (28).
The lack of full recovery of Ca21 response in desen-
sitized pituitary cells could be related to a depleted
intracellular Ca21 pool. This was verified by using
ionomycin 120 min after a desensitizing treatment
with ANG II. We found that Ca21 stores had fully
recovered by that time, suggesting that Ca21 pool de-
pletion might not account for ANG II-induced desensi-
tization. In contrast, it has been described that gona-
dotropin-releasing hormone-induced desensitization of
calcium response in the pituitary rapidly recovers (37)
in parallel with a rapid replenishment of Ca21 stores
(23).
Desensitization was accompanied by a decrease of
PLC-b function, as assessed by measurement of InsP3
and by a decrease in prolactin release in response to a
second stimulus of ANG II. Desensitization in all cases
was not complete, because a response of 54 to 72%
could be obtained depending on the parameter mea-
sured. A similar degree of desensitization of Ins(1,4,5)P3
response to ANG II has been described in cultured
smooth muscle cells (20) and in CHO cells stably trans-
fected with the AT1A receptor (9). This suggests that
the desensitized Ca21 response could be due to im-
paired InsP3 production. The fact that the prolactin
response was also desensitized would indicate that
lactotropes are target cells of ANG II-induced desensi-
tization. Nevertheless, response of corticotropes could
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also be involved, inasmuch as it has been described
that AT1B receptors are present in both lactotropes and
corticotropes in the pituitary, lactotropes being the
predominant cell type in the female pituitary (22).
ANG II pretreatment also desensitized TRH-induced
Ca21 mobilization, InsP3 generation, and prolactin re-
lease. This would indicate that a common element in
the signal transduction pathway of ANG II and TRH
was desensitized by ANG II. In this regard, both ANG
II and TRH receptors interact with the pertussis toxin-
insensitive Gq/G11 class of G proteins (19, 29). It has
been proposed that, within any given cell, there is a
limited pool of G proteins shared by a variety of endog-
enous receptors. It is possible that ANG II receptor
stimulation and subsequent receptor uncoupling, or
receptor G protein internalization, limits the G protein
pool available to couple to other endogenously ex-
pressed receptors, in this case the TRH receptor.
Current evidence suggests that the initial, most
rapid phase of desensitization occurs with a time
course of seconds to minutes after exposure to an
agonist and involves agonist-induced phosphorylation
of GPCRs, uncoupling of the receptors from G proteins,
and a loss of subsequent downstream events (7, 13).
GPCRs can be phosphorylated by two different types of
kinases: 1) second messenger-activated kinases, such
as protein kinase A or PKC, which produce a negative
feedback and a nonspecific mechanism of desensitiza-
tion, and 2) specific kinases that form the growing
family of G protein-coupled receptor kinases, which
phosphorylate only the activated, or agonist-occupied,
forms of GPCRs (13). Phosphorylation and regulation
of GPCRs by second messenger-activated protein ki-
nases are commonly suggested to play a role in heter-
ologous desensitization of GPCRs.
Because both ANG II and TRH activate PKC, it is
possible that this kinase might play an important role
in heterologous desensitization. Because PKC does not
discriminate between agonist-occupied and unoccupied
receptors (13), activation of PKC is believed to be
associated with both homologous and heterologous de-
sensitization.
When PKC activation was prevented by 24 h of prior
exposure to PMA, homologous and heterologous desen-
sitization induced by ANG II still occurred, suggesting
that this process is independent of PKC activation.
Similar results for ANG II have been described in
cardiomyocytes (38), bovine adrenal glomerulosa cells
(6), and CHO cells transfected with the AT1A receptor
(9). It has also been reported that PKC inhibition
reduced agonist-induced phosphorylation of the AT1A
receptor but did not affect its desensitization (25).
Nevertheless, the PKC independence has not been a
universal finding, because inhibitors of PKC prevented
ANG II-mediated desensitization in vascular smooth
muscle cells (26), glomerular mesangial cells (24, 27),
and Xenopus oocytes (30), or they partially reverted
ANG II-induced heterologous desensitization in CHO
cells (33). These results confirm that different mecha-
nisms of desensitization occur for the same agonist in
different cell types.
Another possible mechanism involved in heterolo-
gous desensitization would be downregulation of the
Ins(1,4,5)P3 receptor, which has been shown to partic-
ipate in heterologous desensitization of responses to
ANG II in a rat liver epithelial cell line (5). Neverthe-
less, that event was observed only after longer treat-
ments. Results from the present study suggest that the
observed reduction in InsP3 formation per se could
explain the decrease in intracellular Ca21 mobiliza-
tion.
Desensitization is a complex process that plays an
important role in turning off receptor-mediated signal
transduction pathways. Although rapid desensitiza-
tion appears to be a feature common to PLC-linked
receptors, the extent and persistence of desensitization
have been reported to vary from receptor to receptor.
We provide evidence that ANG II induces homologous
and heterologous desensitization of [Ca21]i mobiliza-
tion, InsP3 formation, and prolactin release in pitu-
itary cells by a mechanism that does not involve PKC
activation. Desensitization was rapid in onset and long
lasting, although it was not complete because partial
responses could be obtained. Time and concentration
patterns of desensitization presented similarities and
differences with respect to endogenously expressed or
transfected AT1 receptors in different cell types. In
light of the development of antihypertensive treat-
ments that use selective AT1 receptor or angiotensin
converting enzyme antagonists, it is important to gain
an insight into the physiology of ANG II in the different
organs in which it might have an impact.
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